AMS (Advanced Medical Strategies) Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • AMS (Advanced Medical Strategies)'s estimated annual revenue is currently $13.1M per year.(i)
  • AMS (Advanced Medical Strategies)'s estimated revenue per employee is $285,261

Employee Data

  • AMS (Advanced Medical Strategies) has 46 Employees.(i)
  • AMS (Advanced Medical Strategies) grew their employee count by 10% last year.

AMS (Advanced Medical Strategies)'s People

NameTitleEmail/Phone
1
CEO & FounderReveal Email/Phone
2
Executive Assistant to CEOReveal Email/Phone
3
Co-Founder & PresidentReveal Email/Phone
4
SVP, ProductReveal Email/Phone
5
VP, Clinical Informatics at Advanced Medical StrategiesReveal Email/Phone
6
VP ComplianceReveal Email/Phone
7
Chief Strategy Officer (CSO)Reveal Email/Phone
8
Founder/Chief Medical OfficerReveal Email/Phone
9
Medical DirectorReveal Email/Phone
10
Cost Analysis/Clinical Data ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.7M3338%N/AN/A
#2
$159.6M3978%N/AN/A
#3
$16.3M6219%N/AN/A
#4
$71M21014%N/AN/A
#5
$1.1M3-50%N/AN/A
#6
$13.9M574%N/AN/A
#7
$184.3M54646%N/AN/A
#8
$324.3M98448%N/AN/A
#9
$14.8M653%$9MN/A
#10
$5.3M220%N/AN/A
Add Company

What Is AMS (Advanced Medical Strategies)?

Mitigate high-cost claim overpayments and predict future liabilities by turning raw claims data into actionable strategic intelligence. Focused solely on the most expensive and complex claims, our AI-driven platform forensically identifies, financially analyzes, methodically predicts and clinically evaluates treatment appropriateness. The results allow payers and risk entities to effectively manage their plan and project risk. After all... Knowledge Is Power.

keywords:N/A

N/A

Total Funding

46

Number of Employees

$13.1M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.7M835%N/A
#2
$27.8M9639%N/A
#3
$17.4M11411%N/A
#4
$43.4M18836%N/A
#5
$148.8M441-12%N/A